Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Mov Disord. 2020 Nov 30:10.1002/mds.28406. doi: 10.1002/mds.28406

Table 2.

Other Pathological Diagnoses and Medication Response

Diagnosis Patients Female Onset Age (yr; mean±SD) Duration (yr; mean±SD) Medication Response Dyskinesias Wearing off
marked moderate nil
vascular disease 7 2 74.2±4.8 10.7±5.3 - 3 4 - 2
Alzheimer disease 2 1 60.5±3.5 7.7±2.5 - - 2 - -
NBIA 2 - 63.8±10.2 7.1±5.6 - 1 1 - -
PART 2 1 70.5±0.7 16.8±6.4 - 1 1 - 1
CJD 1 - 75.1 7.5 - - 1 - -
AGD 1 - 72.0 13.6 - - 1 - -
Huntington disease 1 - 24.0 18.1 - 1 - - -
mitochondrial mutation 1 1 51.0 11.7 - 1 - - -
HIE 1 - 67.0 18.7 - - 1 - -
NPH 1 1 70.0 13.5 - - 1 - -
unexplained 5 3 64.4±17.1 11.8±4.4 0 2 3 2 2

NBIA: neurodegeneration with brain iron accumulation

PART: primary age-related tauopathy

CJD: Creutzfeld-Jakob disease

AGD: argyrophilic grain disease

HIE: hypoxic-ischemic encephalopathy

NPH: normal pressure hydrocephalus